Cure with SR18662 significantly minimizes growth and proliferation of CRC cells. SR18662 reveals enhanced efficacy in decreasing viability of various CRC cell lines. Movement cytometry Assessment pursuing SR18662 treatment shows an increase in cells captured in either S or G2/M phases from the cell cycle and a major boost in https://vonx863otx6.verybigblog.com/profile